Acadia Pharmaceuticals (ACAD) EBITDA Margin Growth (3y) (2013 - 2026)
Acadia Pharmaceuticals (ACAD) EBITDA Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 9,942.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 530.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1,211.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -623.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Acadia Pharmaceuticals | 4.23 Bn | 3.38 Bn | 243.27 Mn | 4,351.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4,351.00 |
| Dec 31, 2025 | 3,987.00 |
| Sep 30, 2025 | 3,645.00 |
| Jun 30, 2025 | 3,724.00 |
| Mar 31, 2025 | 10,577.00 |
| Dec 31, 2024 | 9,328.00 |
| Sep 30, 2024 | 2,426.00 |
| Jun 30, 2024 | 5,051.00 |
| Mar 31, 2024 | 7,005.00 |
| Dec 31, 2023 | 7,063.00 |
| Sep 30, 2023 | 4,395.00 |
| Jun 30, 2023 | 4,181.00 |
| Mar 31, 2023 | 5,415.00 |
| Dec 31, 2022 | 2,361.00 |
| Sep 30, 2022 | 2,441.00 |
| Jun 30, 2022 | 4,361.00 |
| Mar 31, 2022 | 4,132.00 |
| Dec 31, 2021 | 7,878.00 |
| Sep 30, 2021 | 9,346.00 |
| Jun 30, 2021 | 7,436.00 |